With 30+ years’ experience in pulmonary and nasal delivery, Catalent offers integrated solutions with clinical to commercial scale development and manufacturing capabilities for dry powder inhalers, vials for nebulization as well as unit-dose, bi-dose, and multi-dose nasal products. In addition, Catalent provides comprehensive analytical, bioanalytical and clinical supply services to support your molecule from development through product launch and beyond. With state-of-the-art facilities in Boston, Massachusetts, and Morrisville, North Carolina, Catalent can handle the most complex projects and help bring your inhaled therapy to market, faster.
Catalent
200 Crossing Boulevard, 7th Floor
Bridgewater, NJ 08807
USA
+1 855 290 7966
www.catalent.com/specialty/
sales@catalent.com
Catalent Inhalation Capabilities
Learn about the capabilities of Catalent's inhalation network, supporting the development and manufacture of formulations delivered by dry powder inhalers, vials for nebulization as well as unit-dose, bi-dose, and multi-dose nasal products.
More Info
Dry Powder Inhalers (DPIs)
Catalent offers best-in-class clinical and commercial-scale powder and capsule manufacture for dry powder inhalers and is equipped with industry-leading spray dry dispersion, powder encapsulation and blister packaging technologies.
More Info
Nasal Development and Manufacturing
Catalent provides comprehensive end-to-end solutions for formulation development, spray characterization, process optimization and manufacturing for liquid and powder, unit-dose, bi-dose, and multi-dose nasal products.
More Info
Inhalation Development & Analytical Services
Catalent provides end-to-end support for inhalation products, from early pre-formulation work to finished product release testing. As a leader in the development and characterization of inhalation products, we are able to provide the turnkey analytical support services throughout your product’s lifecycle.
More Info
